Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Estrella Immunopharma Inc (ESLA)

Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Estrella Immunopharma Inc 5858 Horton Street Suite 370 Emeryville CA 95608 USA

www.estrellabio.com Employees: 3 P: 510-318-9098

Sector:

Medical

Description:

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS(R) T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The company's lead product candidate includes EB103 and EB104. Estrella Immunopharma Inc., formerly known as TradeUP Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 49,096
Enterprise Value, $K 48,176
Shares Outstanding, K 37,766
Float, K 16,957
% Float 44.90%
Short Interest, K 864
Short Float 2.29%
Days to Cover 8.73
Short Volume Ratio 0.59
% of Insider Shareholders 55.10%
% of Institutional Shareholders 0.35%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -7,312 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,800 K
EBIT, $ -12,440 K
EBITDA, $ -12,440 K

Growth:

1-Year Return 7.08%
3-Year Return -87.34%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/12/25
Next Earnings Date 11/13/25
Earnings Per Share ttm -0.34
EPS Growth vs. Prev Qtr 13.33%
EPS Growth vs. Prev Year -44.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ESLA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -411.91%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.27
Interest Coverage 0.00
60-Month Beta 0.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar